Dr. Anil Kumar Muthineni 2022. Efficacy And Safety Of Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis: A Phase Iii Randomized, Double-Blind, Placebo-Controlled Trial. Journal for ReAttach Therapy and Developmental Diversities. 5, 2 (Dec. 2022), 776–781. DOI:https://doi.org/10.53555/jrtdd.v5i2.3852.